Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.87
+4.72 (2.35%)
AAPL  265.72
+1.84 (0.70%)
AMD  202.42
-0.66 (-0.32%)
BAC  53.41
+0.66 (1.26%)
GOOG  305.15
+2.33 (0.77%)
META  642.49
+3.20 (0.50%)
MSFT  401.28
+4.42 (1.11%)
NVDA  189.19
+4.22 (2.28%)
ORCL  156.81
+2.84 (1.85%)
TSLA  414.70
+4.07 (0.99%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.